Phreesia (NYSE: PHR) officer Evan Roberts boosts holdings via option exercise

Rhea-AI Filing Summary

Phreesia, Inc. officer Evan Roberts, President, Provider Solutions, reported stock option exercises that increased his direct common stock holdings. On 12/17/2025, he exercised options to acquire 44,935 shares of common stock at an exercise price of $4.71 per share and another 5,065 shares at $8.03 per share.

Following these transactions, Roberts directly beneficially owned 840,949 shares of Phreesia common stock. After the exercises, one option grant covering 44,935 shares was fully used, and another grant covering 5,065 shares remained outstanding as part of a larger option position of 17,690 derivative securities. The filing notes that the exercised option was fully vested and exercisable as of the transaction date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roberts Evan

(Last) (First) (Middle)

C/O PHREESIA, INC.

1521 CONCORD PIKE, SUITE 301 PMB 221

(Street)

WILMINGTON DE 19803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Phreesia, Inc. [ PHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Provider Solutions

3. Date of Earliest Transaction (Month/Day/Year)
12/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/17/2025		M		44,935	A	$4.71	835,884	D
Common Stock	12/17/2025		M		5,065	A	$8.03	840,949	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.03	12/17/2025		M			5,065	(1)	03/26/2029	Common Stock	5,065	$0	17,690	D
Stock Option (Right to Buy)	$4.71	12/17/2025		M			44,935	(1)	01/30/2028	Common Stock	44,935	$0	0	D

Explanation of Responses:

1. This option was fully vested and exercisable as of the date of the reported transaction.

	/s/ Allison Hoffman by Power of Attorney for Evan Roberts	12/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Phreesia (PHR) report for Evan Roberts?

Phreesia reported that officer Evan Roberts, President, Provider Solutions, exercised stock options on 12/17/2025 to acquire common shares of the company.

How many Phreesia (PHR) shares did Evan Roberts acquire in this Form 4 filing?

Evan Roberts acquired 44,935 Phreesia common shares at $4.71 per share and 5,065 shares at $8.03 per share through option exercises on 12/17/2025.

What is Evan Roberts' total beneficial ownership of Phreesia (PHR) stock after the reported transactions?

After the reported option exercises, Evan Roberts directly beneficially owned 840,949 shares of Phreesia common stock.

What happened to the stock options that Evan Roberts exercised at Phreesia (PHR)?

Roberts exercised an option for 44,935 shares at $4.71 per share, leaving 0 derivative securities in that grant, and exercised 5,065 shares from another option at $8.03 per share, with 17,690 derivative securities remaining in that position.

Were the Phreesia (PHR) stock options exercised by Evan Roberts vested?

Yes. The filing states that the option was fully vested and exercisable as of the date of the reported transaction.

What are the expiration dates of the Phreesia (PHR) stock options referenced in this Form 4?

The option grant with an exercise price of $8.03 per share has an expiration date of 03/26/2029, and the grant with an exercise price of $4.71 per share has an expiration date of 01/30/2028.